• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Quotient Bioresearch Acquires Edinburgh Facility

Quotient Bioresearch Acquires Edinburgh Facility

May 26, 2009
CenterWatch Staff

U.K.-based Quotient Bioresearch acquired an Edinburgh clinical research facility to supplement the company’s growing clinical research business.

The Cambridgeshire, England, company purchased the facility from Charles River Laboratories last week for an undisclosed sum. The new facility will combine with Pharmaceutical Profiles, a Nottingham, UKbased facility acquired by Quotient in December, to form Quotient Clinical, Quotient’s new strategic business unit. This is Quotient’s sixth acquisition in three years.

“Quotient wasn’t able to participate in clinical services at all until the acquisition of Pharmaceutical Profiles and now of the Edinburgh unit. I think combining those two together to form Quotient Clinical is really primarily just a way of communicating our commitment to that area of the R&D process,” said Mark Egerton, managing director of Quotient Clinical and former CEO of Pharmaceutical Profiles. “The services that are offered from the two facilities are very complementary, so Quotient Clinical will be able to offer full service support to take customers from the initial first in- human study through to the proof of concept in a small patient group study.”

Quotient Clinical now has 160 employees (75 from the Charles River acquisition) with a clinical capacity of 100 beds across the two sites in Edinburgh and Nottingham. The company conducts 50 to 60 clinical trials a year, Egerton said, and the backlog for Quotient’s clinical services has increased 300% in the past year.

“We’re going to spend some immediate focus on making sure that we are selling all of our services to all of our customers. The old Pharmaceutical Profiles business got 60% of its business from customers based in the United States whereas the Edinburgh facility got 70% of its business from customers based in Europe, so we’ve got a strong overlapping customer base,” Egerton said.

The company will spend the next six months coalescing the two sites’ services into three service areas: first-in-man through proof of concept, drug development optimization and a service that Quotient calls 14C enabled drug development.

Upcoming Events

  • 15Apr

    Five Telltale Signs You’re Ready for an Electronic TMF System

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Clinical-Trial-Brainstorming

    FDA, Industry Tackle Problem of Including Older Adults in Trials

  • ClinicalTrialNetwork-360x240.png

    National Community-Based Research Network Would Improve Reach of Trials

  • Bottleneck-360x240.png

    Sites Face Trials Bottleneck After Pandemic, But Also Opportunities

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Genetic Research and IBC Oversight Requirements

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing